Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 5/20 | 0.83 |
| ▸ | USP2 | O75604 | 2/20 | 0.83 |
| ▸ | ACHE | P22303 | 8/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10709654 | 1.00 | INMT (0.83) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL2848542 | 1.00 | INMT (0.83) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL5998050 | 0.98 | — | — | |
| SCHEMBL3047 | 0.91 | INMT (1.00) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL20718625 | 0.91 | INMT (0.91) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL6853620 | 0.91 | INMT (1.00) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL3270217 | 0.91 | INMT (0.91) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL2401189 | 0.91 | INMT (1.00) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL2734323 | 0.91 | INMT (1.00) | INMTUSP2ACHESMN1; SMN2TDP1 | |
| SCHEMBL2742282 | 0.91 | INMT (0.91) | INMTUSP2ACHESMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2785726-B1 | ESTER-FUNCTIONAL SILANES AND THE PREPARATION AND USE THEREOF; AND USE OF IMINIUM COMPOUNDS AS PHASE TRANSFER CATALYSTS | DOW SILICONES CORP (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2573092-B1 | Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates | DOW CORNING (US) | 2017-03-29 | — | — | EP | disclosed |
| US-9518072-B2 | Ester-functional silanes and the preparation and use thereof; and use of iminium compounds as phase transfer catalysts | DOW CORNING CORPORATION (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150126676-A1 | Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts | DOW SILICONES CORPORATION | 2015-05-07 | — | — | US | disclosed |
| US-8580886-B2 | Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates | DOW CORNING CORPORATION (US) | 2013-11-12 | — | — | US | disclosed |
| EP-2573092-A1 | Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates | Dow Corning Corporation (US) | 2013-03-27 | — | — | EP | disclosed |
| US-20130072625-A1 | Method for the Preparation and Use of Bis (Alkoxysilylorgano)-Dicarboxylates | DOW CORNING CORPORATION (US) | 2013-03-21 | — | — | US | disclosed |
| US-6794530-B1 | 1,4-ADDITION OF MONOHYDRIC OR POLYHYDRIC ALCOHOLS TO ALPHA , BETA -UNSATURATED NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-21 | — | — | US | disclosed |
| EP-0934925-B1 | Process for the preparation of beta-alkoxy nitriles | BASF AG (DE) | 2002-09-25 | — | — | EP | disclosed |
| US-6166207-A | Preparation of bicyclic amidines and diazacycloalkenes | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-26 | — | — | US | disclosed |
| US-6130347-A | REACTING MONOCHLOROACETIC ESTER WITH HYDROGEN CYANIDE IN BASE PRESENCE; CYANATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-10 | — | — | US | disclosed |
| EP-0934925-A1 | Process for the preparation of beta-alkoxy nitriles | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-11 | — | — | EP | disclosed |
| EP-0080171-B1 | HEAT-INSULATING MOULDING AND PROCESS FOR PREPARING THE SAME | Hitachi, Ltd. (JP) | 1988-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072625-A1 | Method for the Preparation and Use of Bis (Alkoxysilylorgano)-Dicarboxylates | PBRM1, IPMK, BOLA2; BOLA2B | INMT 253/4885USP2 2679/4885ACHE 4732/4885 |
| US-20150126676-A1 | Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts | ICMT, INTS9, HDHD5 | INMT 4/4885USP2 4321/4885ACHE 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.